Infectious Diseases News and Research

RSS

Rapid molecular testing transforms treatment for community-acquired pneumonia

Pneumonia is an inflammatory condition affecting the lungs, typically resulting from an infection with viruses or bacteria.

7 Mar 2024

Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women

The monthly dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine were each found to be safe for HIV prevention among cisgender women who started using one of them in their second trimester of pregnancy, according to findings presented today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

Special insecticide paint shows promise in controlling dengue and zika mosquito vectors in Cabo Verde

Malaria and other illnesses caused by parasites, viruses, and bacteria transmitted by organisms that spread infectious pathogens account for more than 17% of all infectious diseases worldwide.

5 Mar 2024

Researchers examine the immune response of a hypervaccinated individual

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against Covid-19. They learned of his case via newspaper reports.

5 Mar 2024

European initiative aims to advance the understanding of RNA communication

RNA, which stands for ribonucleic acid has become a mainstream word in society due to the COVID-19 RNA vaccine - yet the value of this biomolecule to society could extend to numerous sectors including food security and personalized medicine.

5 Mar 2024

Newly identified antibodies target a hard-to-spot region of the influenza virus

Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.

1 Mar 2024

Latest COVID-19 booster halves risk of moderate or severe disease in adults

The most recent COVID-19 booster shot reduces adults' risk of moderate or severe COVID by more than half, according to a new nationwide data study from September 2023 through January 2024, a period of JN.1 variant dominance.

1 Mar 2024

H5N1 variant spreads between species, endangering wildlife

The highly pathogenic avian influenza virus H5N1 has adapted to spread between birds and marine mammals, posing an immediate threat to wildlife conservation, according to a study from the University of California, Davis, and the National Institute of Agricultural Technology (INTA) in Argentina.

29 Feb 2024

Harnessing artificial intelligence for infectious disease prevention

A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will look at the many ways artificial intelligence can help prevent infectious disease outbreaks including ensuring staff wear personal protective equipment correctly and managing day-to-day hospital activities such as medication prescription and cleaning.

27 Feb 2024

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will highlight the potential artificial intelligence (AI) has to improve the speed and accuracy of investigations into infectious disease outbreaks in hospitals, and potentially provide real time information to stop or prevent them.

27 Feb 2024

DiaCarta partners with OncoAssure for prostate cancer test commercialization

DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.

27 Feb 2024

Innovative Subak tool offers affordable solution for detecting nuclease digestion

A new tool could reduce costs for diagnosing infectious diseases.

27 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO Centers in Haiti.

27 Feb 2024

Omalizumab shows promise in preventing food allergy reactions in children, study finds

A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of Medicine.

25 Feb 2024

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

23 Feb 2024

Infectious Diseases News and Research

Rapid molecular testing transforms treatment for community-acquired pneumonia

Vaginal ring and oral PrEP found to be safe for HIV prevention among pregnant cisgender women

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

Special insecticide paint shows promise in controlling dengue and zika mosquito vectors in Cabo Verde

Researchers examine the immune response of a hypervaccinated individual

European initiative aims to advance the understanding of RNA communication

Newly identified antibodies target a hard-to-spot region of the influenza virus

Latest COVID-19 booster halves risk of moderate or severe disease in adults

H5N1 variant spreads between species, endangering wildlife

Harnessing artificial intelligence for infectious disease prevention

Harnessing artificial intelligence to enhance infectious disease outbreak investigations

DiaCarta partners with OncoAssure for prostate cancer test commercialization

Innovative Subak tool offers affordable solution for detecting nuclease digestion

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Global health boost as new vaccine SKYTyphoid gains WHO prequalification

POINT project seeks to develop innovative strategies for tackling long-term COVID-19 health impact

Collaborative analysis of disease and death drivers in Gaza conflict

Understanding the role played by HIV in pulmonary hypertension

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News